Proceedings of the Ninth International Conference of Drug Regulatory Authorities (ICDRA) - Berlin, Germany 25-29 April 1999
(1999; 102 pages) View the PDF document
Table of Contents
Open this folder and view contentsOpening Ceremony
Open this folder and view contentsGood regulatory practice
Open this folder and view contentsGood certification practice
Open this folder and view contentsCounterfeit drugs: challenges and solutions
Open this folder and view contentsCurrent issues in regulation and quality
Open this folder and view contentsInternational Conference on Harmonization: implementation and implications
Open this folder and view contentsDrug utilization studies
Open this folder and view contentsInternational Conference on Harmonization and the common technical document
Open this folder and view contentsKeynote address
Close this folderGlobal and national efforts to reduce tobacco use
View the documentHow national authorities can promote non-smoking: experience from a European Union country
View the documentInternational implications of the regulation of nicotine products
View the documentPublic health responsibilities of nicotine regulation
View the documentDiscussion
View the documentRecommendations
Open this folder and view contentsElectronic communication in the regulatory process
Open this folder and view contentsTransparency in monitoring the safety of medicines
Open this folder and view contentsPharmaceutical products for use in special groups
Open this folder and view contentsNeed for Bioequivalence
Open this folder and view contentsAntimicrobial resistance: battling the bugs
Open this folder and view contentsSafety issues of plasma-derived medicinal products
Open this folder and view contentsHerbal medicines
Open this folder and view contentsRegulation and access to essential drugs
View the documentParticipants
View the documentBack cover
 

Global and national efforts to reduce tobacco use

Moderators: Dr Zhou Haijun, China, and Dr S. Nightingale, USA

The preceding keynote address by the Director-General of WHO drew attention to the heavy burden of disease due to tobacco smoking, and the need to control tobacco products. This opened discussions prior to the formal introduction of the topic by the two co-moderators.

In introducing the session, reference was made to action taken in this connection by the United States Food and Drug Administration (FDA) as a model for consideration at this forum. Also stressed was the need for political commitment to tobacco control at the highest level.

to previous section to next section
 

Last updated: April 24, 2012